Sameer Jafri, Co-Founder & CEO
Rory Beyer, Co-Founder & COO
Moseley Andrews, Co-Founder Emeritus
Avive is a technology-enabled medical device company that enables a dispatchable ecosystem of available WiFi-connected, rechargeable Automatic External Defibrillators (AEDs).
“Questa is super easy to access. I could ping them and they would jump on a call with me that evening, which is not the case with all VCs. They are thoughtful, provide valuable contributions, and really understand the value of building a great team.”
Sameer Jafri
Co-Founder & CEO
Their story
Sudden cardiac arrest (SCA) claims over 350,000 lives annually in the U.S., yet dated AED technology and slow emergency response times exist during a time of low survival rates. Traditional AEDs are bulky, expensive, and require complex maintenance, seen failing when needed most.
Avive was founded in 2017 by Sameer Jafri, Rory Beyer, and Moseley Andrews to change this reality. Combining Rory and Moseley’s developed AED technology with Sameer’s expertise in SCA prevention, the team set out to revolutionize the industry. Avive’s mission is to increase survival rates by delivering innovative, accessible, and reliable life-saving tools.
Designed for real-world use, Avive’s technology empowers bystanders to act quickly and confidently in emergencies, transforming the SCA response from an intimidating challenge into an achievable action.
.avif)
Our partnership
Our investment in Avive was the culmination of nearly a decade of research into the defibrillator space. Despite persistently low survival rates in the U.S., meaningful innovation in AED technology has remained elusive. With a plethora of clinical data and a FDA approval, we recognized Avive as the solution we had been searching for in this market.
Since investing, we have supported Avive’s growth from a three-person founding team to one of the youngest teams to receive FDA approval for a medical device. We have helped scale manufacturing globally and guided their efforts to bring life-saving AEDs to communities across all 50 U.S. states.
The team involved
“Avive is poised to disrupt a critical, but innovation-starved market – automated external defibrillators.”
Ryan Drant, Founder & Managing Partner
Questa Capital
.avif)